Latest News of ASND
Ascendis Pharma A/S (ASND): Among Hedge Funds' Top Biotech Stock Picks
By Yahoo! Finance |
2 months ago
Ascendis Pharma A/S (NASDAQ:ASND) is a biotech company targeting hormonal disorders and cancer. Its drug Skytrofa treats growth hormone deficiency in children....
Ascendis Pharma A/S (ASND) Stock Price, News, Quote & History - Yahoo Finance
By Yahoo! Finance |
2 months ago
Royalty Pharma and Ascendis Pharma partner to fund development and commercialization of Endocrine Rare Disease products, supporting Yorvipath U.S. launch and corporate goals. The collaboration include...
Ascendis Pharma A/S (ASND) Stock Price, News, Quote & History
By Yahoo! Finance |
4 months ago
Ascendis Pharma A/S is a biopharmaceutical company specializing in therapies for unmet medical needs, such as SKYTROFA for growth hormone deficiency. With a focus on rare diseases and oncology, the co...
-
2 Biotech Stocks With Big FDA Decisions Approaching - Here's What Analysts Expect
By Yahoo! Finance | 4 months agoBiotech stocks offer high rewards but come with high risks due to regulatory processes and market uncertainties. Ascendis Pharma and Citius Pharmaceuticals have promising drug candidates with potentia...
-
Ascendis Pharma A/S (ASND) Stock Soared on Unexpected Demand
By Yahoo! Finance | 5 months agoTimesSquare Capital Management's U.S. Small Cap Growth Strategy investor letter for Q1 2024 shows a 5.77% return, with top pick Ascendis Pharma A/S (NASDAQ:ASND) gaining. The company's operating loss ...